Skip to content

Study on the efficacy and safety of magnetic-electrical positioning pressure-sensing pulsed field ablation (PFA) catheter for the treatment of ventricular arrhythmias

Study on the efficacy and safety of magnetic-electrical positioning pressure-sensing pulsed field ablation (PFA) catheter for the treatment of ventricular arrhythmias

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108086
Enrollment
Unknown
Registered
2025-08-25
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular arrhythmia

Interventions

PFA:None

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years old 2. Clearly diagnosed symptomatic ventricular arrhythmias (PVCs =10% load or sustained/non-sustained VT) 3. Agree and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Unstable heart failure, severe valvular disease, etc 2. History of sudden cardiac death 3. Pregnant women 4. Implanted ICD and recent history of frequent electric shock 5.VA Originates near the atrioventricular node or in the proximal conduction system 6. Those who clearly contraindicate radiofrequency or electrophysiological examinations

Design outcomes

Primary

MeasureTime frame
Immediate postoperative ablation success rate (target arrhythmia cannot be induced);Arrhythmia recurrence rate within 3 months (as judged by Holter or implanted monitoring devices);Incidence of major adverse events (cardiac tamponade, atrioventricular block, coronary artery injury, etc.);

Countries

China

Contacts

Public ContactChen Yanbo

Weifang People's Hospital

cyb0222@126.com+86 151 6646 0788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026